Metraipolis › archive › dc_332048fdf4ea

Peri-transplant use of immune checkpoint inhibitors in hepatocellular carcinoma: a transplant oncology perspective on safety, timing, post-transplant… — Europe PMC PMID:42294332

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42294332
DOI
10.3389/fonc.2026.1826765
License (as archived)
solo-consultazione
Archived
2026-11-01T05:22:33.790Z
SHA-256 of the archived text
c06a091dc826aec6763f275dddc487155430264e37b6eb7aaa6c2e6c5d7686d7
Stable URL of this page
https://metraipolis.com/documento/dc_332048fdf4ea

How to cite

Peri-transplant use of immune checkpoint inhibitors in hepatocellular carcinoma: a transplant oncology perspective on safety, timing, post-transplant… — Europe PMC PMID:42294332 — Europe PMC (en), https://europepmc.org/article/MED/42294332 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_332048fdf4ea (Metraipolis archive dc_332048fdf4ea, sha256 c06a091dc826aec6763f275dddc487155430264e37b6eb7aaa6c2e6c5d7686d7)
BibTeX
@misc{dc332048fdf4ea,
  title = {Peri-transplant use of immune checkpoint inhibitors in hepatocellular carcinoma: a transplant oncology perspective on safety, timing, post-transplant… — Europe PMC PMID:42294332},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42294332},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_332048fdf4ea; sha256 c06a091dc826aec6763f275dddc487155430264e37b6eb7aaa6c2e6c5d7686d7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42294332. Agents can read the archived copy with the MCP tool read_document.